Chemogenomic approaches to rational drug design

British Journal of Pharmacology

Volumn 152, Issue 1, 2007, Pages 38-52

  Rognan, D ^a  

^a CNRS   (France)

Author keywords

Chemogenomics; Ligand; Target; Virtual screening

Indexed keywords

LIGAND;

AMINO ACID SEQUENCE; BINDING AFFINITY; COMPUTER MODEL; DATA BASE; DRUG DESIGN; GENE EXPRESSION; GENOME; GENOMICS; IN VITRO STUDY; INFORMATION TECHNOLOGY; MEDICAL RESEARCH; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SCREENING; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; COMPUTER-AIDED DESIGN; DRUG DESIGN; GENE REGULATORY NETWORKS; GENOMICS; HUMANS; IMAGING, THREE-DIMENSIONAL; LIGANDS; METABOLIC NETWORKS AND PATHWAYS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; PROTEIN CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STRUCTURAL HOMOLOGY, PROTEIN; SYSTEMS BIOLOGY;

EID: 34548317031     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707307     Document Type: Review

References (90)

1. An J, Totrov M, Abagyan R (2005). Pocketome via comprehensive identification and classification of ligand binding envelopes. Mol Cell Proteomics 4: 752-761.
2. Artymiuk PJ, Poirrette AR, Grindley HM, Rice DW, Willett P (1994). A graph-theoretic approach to the identification of three-dimensional patterns of amino acid side-chains in protein structures. J Mol Biol 243: 327-344.
3. Attwood TK, Bradley P, Flower DR, Gaulton A, Maudling N, Mitchell AL et al. (2003). PRINTS and its automatic supplement, prePRINTS. Nucleic Acids Res 31: 400-402.
4. Bender A, Glen RC (2004). Molecular similarity: a key technique in molecular informatics. Org Biomol Chem 2: 3204-3218.
5. Bender A, Jenkins JL, Glick M, Deng Z, Nettles JH, Davies JW (2006). 'Bayes affinity fingerprints' improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept? J Chem In Model 46: 2445-2456.
6. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H et al. (2000). The protein data bank. Nucleic Acids Res 28: 235-242.
7. Bhavani S, Nagargadde A, Thawani A, Sridhar V, Chandra N (2006). Substructure-based support vector machine classifiers for prediction of adverse effects in diverse classes of drugs. J Chem Inf Model 46: 2478-2486.
8. Bock JR, Gough DA (2005). Virtual screen for ligands of orphan G protein-coupled receptors. J Chem Inf Model 45: 1402-1414.
9. Bondensgaard K, Ankersen M, Thogersen H, Hansen BS, Wulff BS, Bywater RP (2004). Recognition of privileged structures by G-protein coupled receptors. J Med Chem 47: 888-899.
10. Caron PR, Mullican MD, Mashal RD, Wilson KP, Su MS, Murcko MA (2001). Chemogenomic approaches to drug discovery. Curr Opin Chem Biol 5: 464-470.
11. Casbon J, Saqi MA (2005). S4: structure-based sequence alignments of SCOP superfamilies. Nucleic Acids Res 33: D219-D222.
12. Cases M, Garcia-Serna R, Hettne K, Weeber M, van der Lei J, Boyer S et al. (2005). Chemical and biological profiling of an annotated compound library directed to the nuclear receptor family. Curr Top Med Chem 5: 763-772.
13. Chen YZ, Zhi DG (2001). Ligand-protein inverse docking and its potential use in the computer search of protein targets of a small molecule. Proteins 43: 217-226.
14. Chuaqui C, Deng Z, Singh J (2005). Interaction profiles of protein kinase-inhibitor complexes and their application to virtual screening. J Med Chem 48: 121-133.
15. Clark M (2005). Generalized fragment-substructure based property prediction method. J Chem Inf Model 45: 30-38.
16. Crossley R (2004). The design of screening libraries targeted at G-protein coupled receptors. Curr Top Med Chem 4: 581-588.
17. Deng Z, Chuaqui C, Singh J (2004). Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein-ligand binding interactions. J Med Chem 47: 337-344.
18. Deng Z, Chuaqui C, Singh J (2006). Knowledge-based design of target-focused libraries using protein-ligand interaction constraints. J Med Chem 49: 490-500.
19. Evans BE, Rittle KE, Bock MG, DiPardo RM, Freidinger RM, Whitter WL et al. (1988). Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J Med Chem 31: 2235-2346.
20. Feldman HJ, Snyder KA, Ticoll A, Pintilie G, Hogue CW (2006). A complete small molecule dataset from the protein data bank. FEBS Lett 580: 1649-1653.
21. Fernandez A (2005). Incomplete protein packing as a selectivity filter in drug design. Structure 13: 1829-1836.
22. Fernandez A, Maddipati S (2006). A priori inference of cross reactivity for drug-targeted kinases. J Med Chem 49: 3092-3100.
23. Fernandez A, Rogale K, Scott R, Scheraga HA (2004). Inhibitor design by wrapping packing defects in HIV-1 proteins. Proc Natl Acad Sci USA 101: 11640-11645.
24. Ferrara P, Gohlke H, Price DJ, Klebe G, Brooks III CL (2004). Assessing scoring functions for protein-ligand interactions. J Med Chem 47: 3032-3047.
25. Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, Lassmann T et al. (2006). Pfam: clans, web tools and services. Nucleic Acids Res 34: D247-D251.
26. Frimurer TM, Ulven T, Elling CE, Gerlach LO, Kostenis E, Hogberg T (2005). A physicogenetic method to assign ligand-binding relationships between 7TM receptors. Bioorg Med Chem Lett 15: 3707-3712.
27. Fukunishi Y, Kubota S, Nakamura H (2006). Noise reduction method for molecular interaction energy: application to in silico drug screening and in silico target protein screening. J Chem Inf Model 46: 2071-2084.
28. Gardiner EJ, Artymiuk PJ, Willett P (1997). Clique-detection algorithms for matching three-dimensional molecular structures. J Mol Graph Model 15: 245-253.
29. Gold ND, Jackson RM (2006). Fold independent structural comparisons of protein-ligand binding sites for exploring functional relationships. J Mol Biol 355: 1112-1124.
30. Holm L, Park J (2000). DaliLite workbench for protein structure comparison. Bioinformatics 16: 566-567.
31. Hoppe C, Steinbeck C, Wohlfahrt G (2006). Classification and comparison of ligand-binding sites derived from grid-mapped knowledge-based potentials. J Mol Graph Model 24: 328-340.
32. Hu L, Benson ML, Smith RD, Lerner MG, Carlson HA (2005). Binding MOAD (Mother of All Databases). Proteins 60: 333-340.
33. Hulo N, Bairoch A, Bulliard V, Cerutti L, De Castro E, Langendijk-Genevaux PS et al. (2006). The PROSITE database. Nucleic Acids Res 34: D227-D230.
34. Jambon M, Imberty A, Deleage G, Geourjon C (2003). A new bioinformatic approach to detect common 3D sites in protein structures. Proteins 52: 137-145.
35. Kauvar LM, Higgins DL, Villar HO, Sportsman JR, Engqvist-Goldstein A, Bukar R et al. (1995). Predicting ligand binding to proteins by affinity fingerprinting. Chem Biol 2: 107-118.
36. Kellenberger E, Muller P, Schalon C, Bret G, Foata N, Rognan D (2006). sc-PDB: an annotated database of druggable binding sites from the Protein Data Bank. J Chem Inf Model 46: 717-727.
37. Kinoshita K, Nakamura H (2003). Identification of protein biochemical functions by similarity search using the molecular surface database eF-site. Protein Sci 12: 1589-1595.
38. Klabunde T, Hessler G (2002). Drug design strategies for targeting G-protein-coupled receptors. Chembiochem 3: 928-944.
39. Koch MA, Schuffenhauer A, Scheck M, Wetzel S, Casaulta M, Odermatt A et al. (2005). Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc Natl Acad Sci USA 102: 17272-17277.
40. Kratochwil NA, Malherbe P, Lindemann L, Ebeling M, Hoener MC, Muhlemann A et al. (2005). An automated system for the analysis of G protein-coupled receptor transmembrane binding pockets: alignment, receptor-based pharmacophores, and their application. J Chem Inf Model 45: 1324-1336.
41. Krejsa CM, Horvath D, Rogalski SL, Penzotti JE, Mao B, Barbosa F et al. (2003). Predicting ADME properties and side effects: the BioPrint approach. Curr Opin Drug Discov Devel 6: 470-480.
42. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. (2001). Initial sequencing and analysis of the human genome. Nature 409: 860-921.
43. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46: 3-26.
44. Marcou G, Rognan D (2006). Optimizing scaffold docking by use of molecular interaction fingerprints. J Chem Info Model 47: 195-207.
45. Matter H, Schwab W (1999). Affinity and selectivity of matrix metalloproteinase inhibitors: a chemometrical study from the perspective of ligands and proteins. J Med Chem 42: 4506-4523.
46. Mestres J, Martin-Couce L, Gregori-Puigjane E, Cases M, Boyer S (2006). Ligand-based approach to in silico pharmacology: nuclear receptor profiling. J Chem Inf Model 46: 2725-2736.
47. Morphy R (2006). The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds. J Med Chem 49: 2969-2978.
48. Muller P, Lena G, Boilard E, Bezzine S, Lambeau G, Guichard G et al. (2006). In silico guided target identification of a scaffold-focused library: 1,3,5-triazepan-2,6-diones as novel phospholipase A2 inhibitors. J Med Chem 49: 6768-6778.
49. Naumann T, Matter H (2002). Structural classification of protein kinases using 3D molecular interaction field analysis of their ligand binding sites: target family landscapes. J Med Chem 45: 2366-2378.
50. Nettles JH, Jenkins JL, Bender A, Davies JW, Glick M (2006). Bridging chemical and biological space: target fishing using 2D and 3D molecular descriptors. J Med Chem 49: 6802-6810.
51. Nidhi, Glick M, Davies JW, Jenkins JL (2006). Prediction of biological targets for compounds using multiple-category Bayesian models trained on chemogenomics databases. J Chem Inf Model 46: 1124-1133.
52. Nussinov R, Wolfson HJ (1991). Efficient detection of three-dimensional structural motifs in biological macromolecules by computer vision techniques. Proc Natl Acad Sci USA 88: 10495-10499.
53. Oloff S, Zhang S, Sukumar N, Breneman C, Tropsha A (2006). Chemometric analysis of ligand receptor complementarity: identifying Complementary Ligands Based on Receptor Information (CoLiBRI). J Chem Inf Model 46: 844-851.
54. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA et al. (2000). Crystal structure of rhodopsin: a g protein-coupled receptor. Science 289: 739-745.
55. Paolini GV, Shapland RH, van Hoorn WP, Mason JS, Hopkins AL (2006). Global mapping of pharmacological space. Nat Biotechnol 24: 805-815.
56. Paul N, Kellenberger E, Bret G, Muller P, Rognan D (2004). Recovering the true targets of specific ligands by virtual screening of the protein data bank. Proteins 54: 671-680.
57. Pieper U, Eswar N, Davis FP, Braberg H, Madhusudhan MS, Rossi A et al. (2006). MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res 34: D291-D295.
58. Pirard B, Matter H (2006). Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis. J Med Chem 49: 51-69.
59. Powers R, Copeland JC, Germer K, Mercier KA, Ramanathan V, Revesz P (2006). Comparison of protein active site structures for functional annotation of proteins and drug design. Proteins 65: 124-135.
60. Raymond JW, Blankley CJ, Willett P (2003). Comparison of chemical clustering methods using graph- and fingerprint-based similarity measures. J Mol Graph Model 21: 421-433.
61. Reeves GA, Dallman TJ, Redfern OC, Akpor A, Orengo CA (2006). Structural diversity of domain superfamilies in the CATH database. J Mol Biol 360: 725-741.
62. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307: 1625-1630.
63. Root DE, Flaherty SP, Kelley BP, Stockwell BR (2003). Biological mechanism profiling using an annotated compound library. Chem Biol 10: 881-892.
64. Rosen M, Lin SL, Wolfson H, Nussinov R (1998). Molecular shape comparisons in searches for active sites and functional similarity. Protein Eng 11: 263-277.
65. Russ AP, Lampel S (2005). The druggable genome: an update. Drug Discov Today 10: 1607-1610.
66. Sadowski J, Kubinyi H (1998). A scoring scheme for discriminating between drugs and nondrugs. J Med Chem 41: 3325-3329.
67. Savchuk NP, Balakin KV, Tkachenko SE (2004). Exploring the chemogenomic knowledge space with annotated chemical libraries. Curr Opin Chem Biol 8: 412-417.
68. Schmitt S, Kuhn D, Klebe G (2002). A new method to detect related function among proteins independent of sequence and fold homology. J Mol Biol 323: 387-406.
69. Schnur DM, Hermsmeier MA, Tebben AJ (2006). Are target-family-privileged substructures truly privileged? J Med Chem 49: 2000-2009.
70. Schuffenhauer A, Floersheim P, Acklin P, Jacoby E (2003). Similarity metrics for ligands reflecting the similarity of the target proteins. J Chem Inf Comput Sci 43: 391-405.
71. Sheridan RP, Kearsley SK (2002). Why do we need so many chemical similarity search methods? Drug Discov Today 7: 903-911.
72. Shindyalov IN, Bourne PE (1998). Protein structure alignment by incremental combinatorial extension (CE) of the optimal path. Protein Eng 11: 739-747.
73. Shulman-Peleg A, Nussinov R, Wolfson HJ (2004). Recognition of functional sites in protein structures. J Mol Biol 339: 607-633.
74. Singh J, Deng Z, Narale G, Chuaqui C (2006). Structural interaction fingerprints: a new approach to organizing, mining, analyzing, and designing protein-small molecule complexes. Chem Biol Drug Des 67: 5-12.
75. Snyder KA, Feldman HJ, Dumontier M, Salama JJ, Hogue CW (2006). Domain-based small molecule binding site annotation. BMC Bioinformatics 7: 152.
76. Standley DM, Toh H, Nakamura H (2005). GASH: an improved algorithm for maximizing the number of equivalent residues between two protein structures. BMC Bioinformatics 6: 221.
77. Steindl TM, Schuster D, Laggner C, Langer T (2006). Parallel screening: a novel concept in pharmacophore modeling and virtual screening. J Chem Inf Model 46: 2146-2157.
78. Surgand JS (2006). Développement de nouvelles méthodes bioinformatiques pour l'étude des récepteurs couplés aux protéines G. Thèse de l'Université Louis Pasteur - Strasbourg I: France.
79. Surgand JS, Rodrigo J, Kellenberger E, Rognan D (2006). A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors. Proteins 62: 509-538.
80. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al. (2001). The sequence of the human genome. Science 291: 1304-1351.
81. Vieth M, Higgs RE, Robertson DH, Shapiro M, Gragg EA, Hemmerle H (2004). Kinomics-structural biology and chemogenomics of kinase inhibitors and targets. Biochim Biophys Acta 1697: 243-257.
82. Votano JR, Parham M, Hall LH, Kier LB, Hall LM (2004). Prediction of aqueous solubility based on large datasets using several QSPR models utilizing topological structure representation. Chem Biodivers 1: 1829-1841.
83. Wallace AC, Borkakoti N, Thornton JM (1997). TESS: a geometric hashing algorithm for deriving 3D coordinate templates for searching structural databases. Application to enzyme active sites. Protein Sci 6: 2308-2323.
84. Wang J, Krudy G, Xie XQ, Wu C, Holland G (2006). Genetic algorithm-optimized QSPR models for bioavailability, protein binding, and urinary excretion. J Chem Inf Model 46: 2674-2683.
85. Weber A, Casini A, Heine A, Kuhn D, Supuran CT, Scozzafava A et al. (2004). Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition. J Med Chem 47: 550-557.
86. Weininger D (1988). SMILES 1. Introduction and encoding rules. J Chem Inf Comput Sci 28: 31-36.
87. Willett P (2006). Similarity-based virtual screening using 2D fingerprints. Drug Discov Today 11: 1046-1053.
88. Wu CH, Apweiler R, Bairoch A, Natale DA, Barker WC, Boeckmann B et al. (2006). The Universal Protein Resource (UniProt): an expanding universe of protein information. Nucleic Acids Res 34: D187-D191.
89. Xia X, Maliski EG, Gallant P, Rogers D (2004). Classification of kinase inhibitors using a Bayesian model. J Med Chem 47: 4463-4470.
90. Zhang Z, Grigorov MG (2006). Similarity networks of protein binding sites. Proteins 62: 470-478.